Sort   by:  
 Page size 
Quantitative label free proteomics of BioID enriched proteins
ORGANISM(S): Homo sapiens (Human) 
2026-03-26 | PXD047630 | Pride
Label free quantitative LC-MS/MS anaysis of BioID enriched proteins.
ORGANISM(S): Homo sapiens (Human) 
2026-03-26 | PXD047629 | Pride
TurboID of EWS-FLI1 and EWS-P3 fusion proteins coupled with nanoscale capillary chromatography and label free quantitation.
ORGANISM(S): Homo sapiens (Human) 
2026-03-26 | PXD051746 | Pride
Mass spectrometry-based omics technologies are of increasing relevance for drug discovery. In order to map drug treatments to biological pathways for mode of action (MoA) deconvolution, they rely on the determination of multiple testing corrected significant molecular events. The main contributors t...
ORGANISM(S): Homo sapiens (Human) 
2025-04-22 | PXD051069 | Pride
The organometallic gold(I) bis-N-heterocyclic carbene complex [Au(9-methylcaffeine-8-ylidene)2]+ (AuTMX2) was previously shown to selectively and potently stabilise telomeric DNA G-quadruplex (G4) structures. This study sheds light onto the molecular reactivity and mode of action of AuTMX2 in the ce...
ORGANISM(S): Homo sapiens (Human) 
2020-09-17 | PXD020560 | Pride
Despite the increasing prevalence of patients with Long Covid Syndrome (LCS), to date the pathophysiology of the disease is still unclear, and therefore diagnosis and therapy are a complex effort without any standardization. To address these issues, we performed a broad exploratory screening study a...
ORGANISM(S): Homo sapiens (Human) 
2023-03-10 | PXD036970 | Pride
Mass spectrometry-based omics technologies are of increasing relevance for drug discovery. In order to map drug treatments to biological pathways for mode of action (MoA) deconvolution, they rely on the determination of multiple testing corrected significant molecular events. The main contributors t...
ORGANISM(S): Homo sapiens (Human) 
2025-04-22 | PXD039768 | Pride
Sort   by:  
 Page size